Takashi Ura

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

Yasuhiro Matsumura, Tsuyoshi Hamaguchi, Takashi Ura et al. · British Journal of Cancer · 2004 · 617 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui et al. · Journal of Clinical Oncology · 2013 · 559 citations

Medicine, Oncology, Pharmacology +10

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

Tomoya Yokota, Takashi Ura, Norio Shibata et al. · British Journal of Cancer · 2011 · 413 citations · Full text

Medicine, Oncology, Pathology +17

Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

Toshihiro Kudo, Yasuo Hamamoto, Ken Kato et al. · The Lancet Oncology · 2017 · 381 citations

Medicine, Oncology, Pharmacotherapy +7

Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer

Tomoya Yokota, Ken Kato, Yasuo Hamamoto et al. · British Journal of Cancer · 2016 · 146 citations · Full text

Medicine, Oncology, Surgery +14